REACH: non-regulatory announcement
4 December
2024
Aptamer Group
plc
("Aptamer", the "Company" or the "Group")
Investor
Webinar
Aptamer Group plc (AIM: APTA),
the developer of novel Optimer® binders to
enable innovation in the life sciences industry, announces that Dr
Arron Tolley, Chief Executive Officer and Dr David Bunka, Chief
Scientific Officer will be hosting a webinar on
Thursday, 12
December 2024 at 6.00 pm (GMT).
The webinar will provide investors
with a valuable opportunity to interact with the Company and gain
insights into recent announcements.
There will be a Q&A session for
investors after the presentation and questions can be submitted
pre-event as part of the registration process.
You can register for the event by
using the following link:
https://www.turnerpope.com/register/
We are delighted to announce that
the webinar will be chaired by experienced news and corporate
events presenter Katie Pilbeam (www.katiepilbeam.com)
and hosted by the Company's broker, Turner Pope
Investments.
- Ends -
For
further information, please contact:
|
Aptamer Group plc
Arron Tolley, Chief Executive
Officer
|
+44 (0) 1904 217
404
|
|
SPARK Advisory Partners Limited - Nominated
Adviser
Andrew Emmott / Adam
Dawes
|
+44 (0) 20 3368
3550
|
|
Turner Pope Investments (TPI) Limited -
Broker
James Pope / Andrew
Thacker
|
+44 (0) 20 3657
0050
|
|
Northstar Communications Limited - Investor
Relations
Sarah Hollins
|
+44 (0) 113 730 3896
|
About Aptamer Group plc
Aptamer Group develops custom affinity binders through its proprietary
Optimer® platform to enable new approaches in
therapeutics, diagnostics, and research applications. The Company
strives to deliver transformational solutions that meet the needs
of life science researchers and developers.
Optimer binders are oligonucleotide
affinity ligands that can function as an antibody alternative. The
global affinity ligand market is currently worth over $170
billion.
Aptamer has successfully delivered
projects for a range of global pharma companies, diagnostic
development companies, and research institutes, covering multiple
application areas with the objective of establishing
royalty-bearing licenses.
To register for news alerts by email
go to https://aptamergroup.com/investors/investor-news-email-alerts/.